ATLAS CROSSING LLC

Lobbying for RECURSION · Clinical-Stage TechBio Company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Utah · House · Senate · $50,000.00 income · posted Jul 18, 2025

Lobbying activity 1

Science/Technology

Issues related to artificial intelligence and machine learning. Issues related to infectious diseases. Issues related to drug discovery.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.